Gordon Bernard, M.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC), will receive the American College of Critical Care Medicine’s highest honor, the Distinguished Investigator Award, during the Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress in Honolulu in January, 2017.

New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea.

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”